openPR Logo
Press release

Value of Hospital Infection Therapeutics Market to touch US$3.6 bn by 2020 thanks to increasing number of pipeline drug molecules

09-20-2017 02:05 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Value of Hospital Infection Therapeutics Market to touch US$3.6

As per the research study, in 2013, the global market for hospital infection therapeutics was valued at US$3.1 bn and is estimated to reach US$3.6 bn by the end of 2020. The market is predicted to exhibit a 3.10% CAGR between 2014 and 2020.

Hospital-acquired infections are majorly caused by fungal, bacterial, and viral pathogens. Several cases of hospital infections are acquired from the intensive care units of hospitals. A huge number of antimicrobial drugs have demonstrated their capability in treating a wide range of hospital infections. The increasing number of pipeline drug molecules in the hospital infection therapeutics market is one of the biggest opportunities for the growth of the market. In addition, the absence of skilled staff in developing and underdeveloped countries and growing prevalence of several hospital infections are the major factors expected to fuel the growth of the market in the next few years.

View Full Report: http://www.transparencymarketresearch.com/hospital-infection-therapeutics.html

Based on the major prominent types of drugs in the market, the global market for hospital infection therapeutics has been segmented into antiviral, antibacterial, and antifungal drugs. In 2013, the antibacterial drugs segment dominated the market, accounting for a 70.7% share in the global market for hospital infection therapeutics. This segment is projected to grow at a fast pace in the next few years. The research study has further analyzed the major drugs in the pipeline, including Plazomicin, Ceftolozane, Delafloxacin, Eravacycline, Surotomycin, Tedizolid, Amikacin Inhale, MK-3415A, CAZ AVI, Dalvance, and Oritavancin.

Request Sample for this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1280

On the basis of type of infection, the global market for hospital infection therapeutics has been categorized into gastrointestinal disorders, hospital-acquired pneumonia, urinary tract infections, surgical site infections, bloodstream infections, and other infections. In 2013, the hospital-acquired pneumonia segment accounted for a 20% share in the global market for hospital infection therapeutics. Nevertheless, the urinary tract infections segment is anticipated to grow rapidly in the near future.

Request to download and view full ToC: http://www.transparencymarketresearch.com/report-toc/1280

Currently, North America leads the overall market and is estimated to remain in the leading position in the next few years. North America is closely trailed by Europe. The rapid growth of these two regional markets can be attributed to the increasing healthcare awareness and growing demand for advanced drugs. On the other hand, the Asia Pacific market for hospital infection therapeutics is estimated to witness the fastest growth throughout the forecast period.

Global Hospital Infection Therapeutics Market Report is available @ US$ 5795

Furthermore, the research report talks about the competitive scenario of the global market for hospital infection therapeutics. Detailed profiles of the prominent players have been discussed in the scope of the research study. Some of the leading players operating in the market are Bayer AG, Johnson & Johnson Services, Inc., Actavis plc, Sanofi, Bristol-Myers Squibb Company, Merck & Co., Inc., GlaxoSmithKline plc, Pfizer, Inc., AstraZeneca plc, and Cubist Pharmaceuticals, Inc.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Value of Hospital Infection Therapeutics Market to touch US$3.6 bn by 2020 thanks to increasing number of pipeline drug molecules here

News-ID: 729760 • Views:

More Releases from TMR - Research Reports

Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to

All 5 Releases


More Releases for US$3

Palatants Market to Reach ~ US$ 3 Bn by 2027
Mealtime is the happiest time for pets, and every pet owner want to feed quality meals that have enhanced palatability and are rich in nutrients. Around the world, the number of pets has been increasing owing to the aesthetic sense offered by pets. In addition, the sense of social comfort, company, and security are also fueling the demand for pet animals. Factors such as increasing disposable income have led the
Top 3 Industry Sectors in B2B Exhibitions Market in US
The B2B exhibitions market in US is projected to grow from $12.83 billion in 2017 to $36.35 billion by 2023. The market is projected to grow at a CAGR of 4.88% Arizton’s recent market research report on the B2B exhibitions market in the US in US identifies RELX Group, UBM, Informa Exhibitions, and Emerald Expositions as the leading vendors that are likely to dominate the market during the forecast period. This
Proton Therapy Market Stood at US$ 3 Bn by 2024
Key highlights of the research report on global proton therapy market follow: The market is likely to benefit from companies manufacturing compact set up used in proton beam therapy, which help in saving production costs without impairing product efficacy Based on such set ups, multiple-room proton therapy will gain traction by accounting for more than three-fourth of global revenues towards the end of forecast period Among multiple cancer indications, the adoption of proton
Proton Therapy Market Will Amass US$ 3 Bn by 2024
In the report, titled “Proton Therapy Market: Global Industry Analysis and Forecast, 2016-2024,” the global market for proton therapy is presently valued at closed to US$ 945 Mn and is projected to soar at a healthy CAGR of 15.2%. The report estimates that governments from all corners of the globe will continue to shore up their healthcare expenditure on cancer care facilities, which will incidentally boost the revenues in global
LiDAR Market to Cross US$ 3 Billion by 2022
The Global LiDAR Market is segmented on the lines of its type, application and regional. Based on type segmentation it covers airborne LiDAR and terrestrial LiDAR. Under application segmentation it covers coastal, transportation, forestry, infrastructure, transmission lines, defense and aerospace, flood mapping, others such as mining, hydrography etc. The Global LiDAR Market is geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and
Consumer Electronics Market worth US$ 3 Trillion Market by 2020
Strong demand for smartphones, tablets, and LCD/LED TVs in Asia Pacific will continue to fuel the global consumer electronics market. Global revenues are projected to reach nearly US$ 3 trillion in 2020, up from an estimated US$ 1.45 trillion in 2015. The key trends that will shape up the market during the forecast period include, Rising disposable income among the middle class in China and India is